LEADER 02441nam0 22005773i 450 001 VAN00249868 005 20240806101421.466 017 70$2N$a9783030437145 100 $a20220909d2020 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aStatistical Remedies for Medical Researchers$fPeter F. Thall 210 $aCham$cSpringer$d2020 215 $axi, 291 p.$cill.$d24 cm 410 1$1001VAN00114829$12001 $aSpringer Series in Pharmaceutical Statistics$1210 $aBerlin [etc.]$cSpringer 500 1$3VAN00249869$aStatistical Remedies for Medical Researchers$92391162 606 $a62-XX$xStatistics [MSC 2020]$3VANC022998$2MF 606 $a62K20$xResponse surface designs [MSC 2020]$3VANC035615$2MF 606 $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$3VANC024649$2MF 606 $a62R07$xStatistical aspects of big data and data science [MSC 2020]$3VANC026514$2MF 610 $aAdaptive randomization$9KW:K 610 $aAnalysis of medical experiments$9KW:K 610 $aBayesian Statistics$9KW:K 610 $aBias correction$9KW:K 610 $aClinical Trials$9KW:K 610 $aConfounding$9KW:K 610 $aDesign of medical experiments$9KW:K 610 $aDose Finding$9KW:K 610 $aDynamic treatment regimes$9KW:K 610 $aExpansion cohorts$9KW:K 610 $aExperimental design$9KW:K 610 $aHypothesis Testing$9KW:K 610 $aMonitoring toxicity$9KW:K 610 $aP-value$9KW:K 610 $aPhase I Trials$9KW:K 610 $aPrecision medicine$9KW:K 610 $aProbability$9KW:K 610 $aRandomization$9KW:K 610 $aSurvival analysis$9KW:K 620 $aCH$dCham$3VANL001889 700 1$aThall$bPeter F.$3VANV204282$01017963 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20241115$gRICA 856 4 $uhttp://doi.org/10.1007/978-3-030-43714-5$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$1IT-CE0120$2VAN08 912 $fN 912 $aVAN00249868 950 $aBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08DLOAD e-book 4867 $e08eMF4867 20220909 996 $aStatistical Remedies for Medical Researchers$92391162 997 $aUNICAMPANIA